| Part B: Supplementary Information Sheet (SIS) |
|
FR Recognition List Number
|
057
|
Date of Entry 12/20/2021
|
|
FR Recognition Number
|
5-134
|
| Standard | |
ISO 15223-1 Fourth edition 2021-07 Medical devices - Symbols to be used with information to be supplied by the manufacturer - Part 1: General requirements |
|
Scope/AbstractThis document specifies symbols used to express information supplied for a medical device. This document is applicable to symbols used in a broad spectrum of medical devices, that are available globally and need to meet different regulatory requirements.
These symbols can be used on the medical device itself, on its packaging or in the accompanying information. The requirements of this document are not intended to apply to symbols specified in other standards. |
|
| Extent of Recognition
|
Rationale for Recognition
| This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
| FDA recognition of ISO 15223-1 Fourth edition 2021-07 [Rec# 5-134] will be superseded by recognition of ISO 15223-1 Fourth edition 2021-07 [Including AMD1: 2025] [Rec# 5-148]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 5-134] until December 17, 2028. After this transition period, declarations of conformity to [Rec# 5-134] will not be accepted. |
|
Public Law, CFR Citation(s) and Procode(s)*
| Regulation Number |
Device Name |
Device Class |
Product Code |
| 21 CFR Part 660 Biologics, labeling, reporting, and recordkeeping requirements |
| 21 CFR Part 809 Labeling, medical devices |
| 21 CFR Part 801 Labeling, medical devices, reporting and recordkeeping requirements |
|
Relevant FDA Guidance and/or Supportive Publications*
Final Rule, Use of Symbols in Labeling, Issued June 15 2016
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
| FDA Technical Contact
|
| Standards Development Organization
|
| FDA Specialty Task Group (STG)
|
| *These are provided as examples and others may be applicable. |